The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of current programmed death-ligand 1 (PD-L1) testing practices for metastatic non-small cell lung cancer (mNSCLC): Insights from a large network of US community oncology practices.
 
Kathleen Aguilar
Employment - IQvia (I); Ontada/McKesson
Stock and Other Ownership Interests - McKesson
 
Jess Paulus
Employment - Ontada/McKesson
 
Ruben Quek
Employment - Regeneron
 
TG Hager
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Travel, Accommodations, Expenses - Regeneron; Regeneron (I)
 
Chao Chen
Employment - Regeneron
 
Avi Raju
Employment - McKesson
 
Malcolm Charles
No Relationships to Disclose
 
James Harnett
Employment - Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Paul Conkling
Employment - Ontada/McKesson; Virginia Oncology Associates
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly; EMD Serono (Inst); Janssen (Inst)